Founded two years ago, X-MAGTECH has built a core technology platform around atomic magnetometers capable of detecting magnetic fields at one-billionth the strength of Earth’s field. Its products include a multi-channel zero-field atomic magnetometer, a cardiomagnetograph (for which it just received China’s first medical device registration certificate based on this technology), and an in-development magnetoencephalograph. Commercial shipments exceeded 100 units in 2021, serving basic research, biomagnetic detection, and industrial inspection markets. The company positions itself as the only firm worldwide that both controls the underlying quantum magnetic sensing technology and offers commercial heart- and brain-magnetic imaging products. Recent awards—from national entrepreneurship contests to Zhongguancun’s high-tech program—underscore broad recognition of its technical leadership. With fresh capital, X-MAGTECH plans to accelerate R&D, scale manufacturing, and bring its brain and fetal heart magnetography systems to market, aiming to enable early, non-invasive diagnosis of coronary heart disease, fetal congenital heart disease, epilepsy, Alzheimer’s, depression, and more.

Total raised

$28M

Funding rounds

2

Latest round

Series A

Latest activity

Jul 2024